EA199900962A1 - Композиция солюбилизированного сертралина - Google Patents

Композиция солюбилизированного сертралина

Info

Publication number
EA199900962A1
EA199900962A1 EA199900962A EA199900962A EA199900962A1 EA 199900962 A1 EA199900962 A1 EA 199900962A1 EA 199900962 A EA199900962 A EA 199900962A EA 199900962 A EA199900962 A EA 199900962A EA 199900962 A1 EA199900962 A1 EA 199900962A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sertraline
sourobilized
composition
solubility
increases
Prior art date
Application number
EA199900962A
Other languages
English (en)
Other versions
EA002481B1 (ru
Inventor
Дуэйн Томас Фризен
Скотт Макс Хербиг
Рави Майсор Шенкер
Джеймс Блэр Вест
Original Assignee
Пфайзер Продактс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971159&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA199900962(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Пфайзер Продактс Инк. filed Critical Пфайзер Продактс Инк.
Publication of EA199900962A1 publication Critical patent/EA199900962A1/ru
Publication of EA002481B1 publication Critical patent/EA002481B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Abstract

Композиции, содержащие сертралин и солюбилизирующий агент, который увеличивает растворимость сертралина в водных содержащих хлорид-ионы применяемых средах.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900962A 1997-07-01 1998-06-15 Композиция на основе солюбилизированного сертралина EA002481B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5141397P 1997-07-01 1997-07-01
PCT/IB1998/000933 WO1999001120A1 (en) 1997-07-01 1998-06-15 Solubilized sertraline compositions

Publications (2)

Publication Number Publication Date
EA199900962A1 true EA199900962A1 (ru) 2000-08-28
EA002481B1 EA002481B1 (ru) 2002-06-27

Family

ID=21971159

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900962A EA002481B1 (ru) 1997-07-01 1998-06-15 Композиция на основе солюбилизированного сертралина

Country Status (34)

Country Link
EP (1) EP0999829A1 (ru)
JP (1) JP2000514100A (ru)
KR (1) KR100366373B1 (ru)
CN (1) CN1261794A (ru)
AP (1) AP1192A (ru)
AR (3) AR015917A1 (ru)
AU (1) AU742535B2 (ru)
BG (1) BG103918A (ru)
BR (1) BR9810739A (ru)
CA (1) CA2290974C (ru)
CO (1) CO4940495A1 (ru)
DZ (1) DZ2548A1 (ru)
EA (1) EA002481B1 (ru)
HN (1) HN1998000102A (ru)
HR (1) HRP980377A2 (ru)
HU (1) HUP0002236A3 (ru)
ID (1) ID23429A (ru)
IL (1) IL133076A (ru)
IS (1) IS5260A (ru)
MA (1) MA24587A1 (ru)
NO (1) NO996520L (ru)
OA (1) OA11243A (ru)
PA (1) PA8454301A1 (ru)
PE (1) PE97199A1 (ru)
PL (1) PL337804A1 (ru)
SK (1) SK181099A3 (ru)
TN (1) TNSN98124A1 (ru)
TR (1) TR199903297T2 (ru)
TW (1) TW550087B (ru)
UA (1) UA67741C2 (ru)
UY (1) UY25071A1 (ru)
WO (1) WO1999001120A1 (ru)
YU (1) YU68299A (ru)
ZA (1) ZA985708B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1402629A (zh) 1999-12-23 2003-03-12 辉瑞产品公司 提供提高的药物浓度的药物组合物
US20030086972A1 (en) * 2000-08-09 2003-05-08 Appel Leah E. Hydrogel-driven drug dosage form
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
US20040191207A1 (en) * 2003-03-31 2004-09-30 Lipari John M. Alpha-hydroxy acid ester drug delivery compositions and methods of use
EP2117652B1 (en) * 2007-03-12 2013-09-25 DSM IP Assets B.V. Cosmetic compositions
KR20120123289A (ko) * 2009-12-29 2012-11-08 코와 가부시키가이샤 경구 투여용 고형 의약 조성물
KR20120116422A (ko) * 2009-12-29 2012-10-22 코와 가부시키가이샤 경구 투여용 의약 조성물
CN109908354A (zh) * 2017-12-12 2019-06-21 万特制药(海南)有限公司 盐酸舍曲林口服浓缩液及其制备工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
EP0415612B1 (en) * 1989-08-30 1993-11-10 Pfizer Inc. Use of sertraline for the treatment of chemical dependencies
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
CO4940495A1 (es) 2000-07-24
TNSN98124A1 (fr) 2005-03-15
KR20010013365A (ko) 2001-02-26
AR040279A2 (es) 2005-03-23
UA67741C2 (ru) 2004-07-15
TW550087B (en) 2003-09-01
YU68299A (sh) 2002-06-19
TR199903297T2 (xx) 2000-07-21
HUP0002236A3 (en) 2003-12-29
AR015917A1 (es) 2001-05-30
PL337804A1 (en) 2000-09-11
AR040280A2 (es) 2005-03-23
UY25071A1 (es) 2000-12-29
PA8454301A1 (es) 2000-09-29
PE97199A1 (es) 1999-10-05
CA2290974A1 (en) 1999-01-14
ZA985708B (en) 2000-01-10
AP1192A (en) 2003-07-23
MA24587A1 (fr) 1998-12-31
NO996520L (no) 2000-02-29
CA2290974C (en) 2004-04-27
HN1998000102A (es) 1999-01-08
EA002481B1 (ru) 2002-06-27
SK181099A3 (en) 2000-07-11
CN1261794A (zh) 2000-08-02
EP0999829A1 (en) 2000-05-17
AU742535B2 (en) 2002-01-03
ID23429A (id) 2000-04-20
WO1999001120A1 (en) 1999-01-14
AP9801280A0 (en) 1998-06-30
IL133076A (en) 2003-12-10
OA11243A (en) 2003-07-24
KR100366373B1 (ko) 2003-01-14
IL133076A0 (en) 2001-03-19
HUP0002236A2 (hu) 2003-08-28
DZ2548A1 (fr) 2003-02-08
HRP980377A2 (en) 1999-04-30
BR9810739A (pt) 2000-09-12
AU7544898A (en) 1999-01-25
BG103918A (en) 2000-07-31
NO996520D0 (no) 1999-12-28
IS5260A (is) 1999-11-19
JP2000514100A (ja) 2000-10-24

Similar Documents

Publication Publication Date Title
EA199900749A1 (ru) Фармацевтическая композиция
EA199900325A1 (ru) Форма d дигидрата оланзапина
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
EA200200476A1 (ru) Местный нецитотоксичный противомикробный гидрогель с тиксотропными свойствами
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
ES2195970T3 (es) L-ribavirina y usos de la misma.
EA199800667A1 (ru) Новые фенантридины
EA200000868A1 (ru) Ингибиторы фосфолипаз
BR0006005A (pt) Composição estável de óleo em glicerinatopicamente aplicável
HUP9900152A2 (hu) Alkoholalapú mikrobaellenes kozmetikai készítmény és alkalmazása
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
RS49795B (sr) Sredstva sa antidepresivnim dejstvom
GB9717905D0 (en) Lipid-containing compositions and uses thereof
DE69912983D1 (de) Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel
MX9405434A (es) Composicion de peroxido de hidrogeno.
EA199900962A1 (ru) Композиция солюбилизированного сертралина
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
BR9713043A (pt) Composição para limpeza de superfìcies rìgidas.
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
EA199800753A1 (ru) Бензотиофены, составы их содержащие и способы с их использованием
EA200000092A1 (ru) Противоаллергические средства
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
EA199900534A1 (ru) Имидазопиридазины
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
PT929299E (pt) 1,2,3,4-tetra-hidro-2-dibenzofuranaminas e 2-aminociclo-hepta ¬b| benzofuranos substituidos